Signed in as:
filler@godaddy.com
Signed in as:
filler@godaddy.com
Organizations dedicated to developing therapies for rare and orphan diseases and advanced therapies operate under unique pressures. The regulatory environment is complex, demanding rigorous quality control and compliance, yet resources are often constrained. Managing the necessary audits—internal QMS assessments, critical supplier evaluations, and preparing for regulatory inspections—can place a significant burden on your valuable quality and regulatory teams. This necessary activity can divert crucial attention, time, and funding away from your core mission: advancing research, developing life-changing therapies, and supporting patients.
Imagine empowering your expert teams to fully dedicate their time to accelerating therapy development, navigating complex manufacturing challenges for novel modalities (like ATMPs), managing change effectively, and strengthening the verification and validation essential for patient safety, rather than being consumed by the demanding audit cycle.
Regal Intel offers a specialized solution: comprehensive audit outsourcing services tailored specifically to the needs of the rare disease community. By partnering with us, you can strategically entrust your audit functions to experienced professionals who understand your context, ensuring robust compliance while freeing up your internal resources to focus where they matter most.
Maintaining a comprehensive in-house audit program within the often resource-constrained rare disease environment involves significant direct and indirect costs that impact your ability to deliver on your mission.
Direct Costs:
Indirect Costs:
Regal Intel provides expert audit services with a deep understanding of the rare disease regulatory landscape and a commitment to supporting your mission. As a non-profit ourselves, we understand the ecosystem. Our experienced auditors possess specialized expertise across all audit types relevant to rare disease programs, including:
Partnering with Regal Intel for your audit functions allows your organization to optimize resource allocation and enhance focus:
The significant resource optimization achieved through partnership with Regal Intel can be strategically reinvested to directly fuel your core objectives:
Track the positive impact of partnering with Regal Intel through key indicators relevant to your mission:
In the demanding field of rare diseases and advanced therapy, optimizing every resource to advance your mission is paramount. Regal Intel offers a strategic, non-profit partnership to alleviate the burden of audits, ensuring robust compliance while allowing you to reinvest valuable resources in what matters most – developing and delivering life-changing therapies to patients.
Contact Regal Intel today to discuss how our tailored outsourced audit partnership can support your organization.
Copyright © 2025 Regal Intel - All Rights Reserved.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.